Compare

Carpenter Technology/$CRS

1D1W1M3M6MYTD1Y5YMAX

About Carpenter Technology

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.
Ticker
$CRS
Primary listing
NYSE
Employees
4,500

CRS Metrics

BasicAdvanced
$13B
23.63
$11.34
1.41
$0.80
0.30%

What the Analysts think about CRS

Analyst ratings (Buy, Hold, Sell) for Carpenter Technology stock.
Analyst projections of the future price of Carpenter Technology stock.

Bulls say / Bears say

First-quarter operating income rose 28% year on year to a record $196.4 million, while the company maintained its fiscal 2027 outlook for $850 million to $880 million. The Specialty Alloys segment’s adjusted operating margin was 37.7%, supported by productivity, pricing and product mix. (Carpenter Technology Corporation)
Commercial aerospace orders are strengthening: bookings in structural and distribution rose 49% year on year, while engine bookings increased 22%. Aerospace and defence sales excluding surcharges also grew 10% year on year in the quarter. (Carpenter Technology Corporation)
The Athens expansion is designed to add 9,000 tons of capacity and begin production in fiscal 2028, giving Carpenter room to serve future demand. Fitch cites high barriers to entry and expects the project to support the company’s growth. (Fitch Ratings)
Defence bookings fell both sequentially and year on year as customers faced delays in funding. If budget clarity or order flow is slow to improve, expected defence demand may not translate into near-term sales. (Investing.com)
Growth is uneven outside aerospace and defence: first-quarter sales excluding surcharges fell 16% year on year in medical and 23% in energy. Weakness in these markets limits the support that Carpenter’s broader end-market mix can provide. (Carpenter Technology Corporation)
First-quarter free cash flow was negative $24.8 million as capital spending on the expansion rose to $77.7 million. Carpenter has warned that delays, cost overruns or difficulty qualifying new capacity could harm results, so the project brings execution risk before its expected benefits arrive. (Carpenter Technology Corporation, U.S. Securities and Exchange Commission)
Data summarised monthly by Lightyear AI. Last updated on 18 Nov 2026.

CRS Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

CRS Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.